Dermatology Excimer Laser Launched by Ra Medical Systems

Ra Medical Systems Inc. has launched  Pharos, Optimized, the next generation of Pharos excimer lasers, designed to enhance physician and patient experience with faster treatments for psoriasis, vitiligo, and atopic dermatitis; extended peak performance; and a new ergonomic handpiece for operator comfort and greater treatment site visibility.
 
“Pharos has added significant value to my dermatology practice by quickly and painlessly treating stubborn conditions: psoriasis, vitiligo, and atopic dermatitis,” said David J. Goldberg, M.D. “Faster treatments from the optimized Pharos laser will increase patient satisfaction and motivate patients to complete the full treatment regimen to achieve the best possible outcomes.” Dr. Goldberg is a widely-published, world-renowned dermatologic laser expert and is the director of Skin Laser & Surgery Specialists of New York and New Jersey.
 
Psoriasis,¹ vitiligo,² and atopic dermatitis³ collectively affect more than 25 million people in the United States. Pharos, Optimized brings together 15 years of proven clinical success treating these conditions with a user-centered design that reflects customer experience with millions of procedures in the United States and 14 countries worldwide.
 
“The Pharos excimer laser is a workhorse in my practice, treating chronic skin conditions that affect large patient populations. With Pharos, I achieve clinical success clearing plaques and re-pigmenting lesions that have not responded to other treatments,” said Tien Q. Nguyen, M.D. “Ra Medical Systems provides excellent clinical and post-sales support with no recurring per treatment expense to my practice.” Dr. Nguyen is the director of First OC Dermatology in Irvine and Fountain Valley, Calif.
 
Pharos is the only excimer laser to feature integrated adjustable aiming and laser beams to deliver precisely targeted treatments that spare healthy tissue. The laser’s small footprint enables it to fit into any treatment room, saving valuable floor space.
 
“The optimized Pharos is a next generation laser that delivers what dermatologists have been asking for: faster treatments for psoriasis, vitiligo, and atopic dermatitis and an upgraded user and patient experience,” said Dean Irwin, CEO, Ra Medical Systems Inc.
 
Learn more about Pharos, Optimized by watching this video.
 
Ra Medical Systems is a commercial medical device company developing and marketing excimer laser systems for the treatment of vascular and dermatologic diseases. DABRA launched in 2017 for the endovascular treatment of blockages resulting from lower extremity vascular disease. Pharos launched in 2004 for the treatment of dermatological disorders including psoriasis, vitiligo, and atopic dermatitis. DABRA and Pharos are based on Ra Medical’s core excimer laser technology platform that produces 308 nanometer light, a UVB wavelength that studies have demonstrated increases T-cell apoptosis, or cell death, which may produce a beneficial, targeted immunosuppressive effect. Ra Medical manufactures DABRA and Pharos excimer lasers and catheters in a 32,000-square-foot facility located in Carlsbad, California. The vertically integrated facility is ISO 13485-certified and is licensed by the state of California to manufacture sterile, single-use catheters in controlled environments.

References
¹ https://www.psoriasis.org/content/statistics
² https://www.aad.org/File%20Library/Top%20navigation/About/Burden%20of%20Skin%20Disease/Vitiligo.pdf
³ https://nationaleczema.org/research/eczema-facts/